GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

esketamine   Click here for help

GtoPdb Ligand ID: 9152

Synonyms: (S)-(+)-Ketamine | (S)-Ketamine | Spravato®
Approved drug PDB Ligand
esketamine is an approved drug (EMA & FDA (2019))
Compound class: Synthetic organic
Comment: As the ketamine (S) enatiomer esketamine is twice as potent and has a more medically useful pharmacological action than racemic ketamine. Part of this advantage arises from inhibition of dopamine transporters.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 1
Rotatable bonds 2
Topological polar surface area 29.1
Molecular weight 237.09
XLogP 2.88
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CNC1(CCCCC1=O)c1ccccc1Cl
Isomeric SMILES CN[C@@]1(CCCCC1=O)c1ccccc1Cl
InChI InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3/t13-/m0/s1
InChI Key YQEZLKZALYSWHR-ZDUSSCGKSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Kang H, Epstein M, Banke TG, Perszyk R, Simorowski N, Paladugu S, Liotta DC, Traynelis SF, Furukawa H. (2025)
Structural basis for channel gating and blockade in tri-heteromeric GluN1-2B-2D NMDA receptor.
Neuron, [Epub ahead of print]. [PMID:39954679]
2. Yi F, Bhattacharya S, Thompson CM, Traynelis SF, Hansen KB. (2019)
Functional and pharmacological properties of triheteromeric GluN1/2B/2D NMDA receptors.
J Physiol, 597 (22): 5495-5514. [PMID:31541561]